Kangji Medical Holdings
Market Cap
HK$12.3b
Last Updated
2021/04/19 10:26 UTC
Data Sources
Company Financials +
Executive Summary
Kangji Medical Holdings Limited, through its subsidiaries, engages in the research, development, manufacture, and sale of minimally invasive surgical instruments and accessories in China. More Details
Rewards
Risk Analysis
No risks detected for 9997 from our risk checks.
Snowflake Analysis
Exceptional growth potential with flawless balance sheet.
Share Price & News
How has Kangji Medical Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 9997 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: 9997's weekly volatility (8%) has been stable over the past year.
Market Performance
7 Day Return
12.2%
9997
-1.2%
HK Medical Equipment
0.7%
HK Market
1 Year Return
n/a
9997
43.4%
HK Medical Equipment
28.1%
HK Market
Return vs Industry: Insufficient data to determine how 9997 performed against the Hong Kong Medical Equipment industry.
Return vs Market: Insufficient data to determine how 9997 performed against the Hong Kong Market.
Shareholder returns
| 9997 | Industry | Market | |
|---|---|---|---|
| 7 Day | 12.2% | -1.2% | 0.7% |
| 30 Day | -4.7% | 6.1% | -0.2% |
| 90 Day | -22.8% | -5.6% | 0.2% |
| 1 Year | n/a | 45.0%43.4% | 33.4%28.1% |
| 3 Year | n/a | 208.5%194.3% | 8.1%-3.8% |
| 5 Year | n/a | 293.6%258.6% | 56.5%28.9% |
Long-Term Price Volatility Vs. Market
How volatile is Kangji Medical Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall St
Analysts Just Slashed Their Kangji Medical Holdings Limited (HKG:9997) EPS Numbers2 months ago | Simply Wall St
Here's Why We Think Kangji Medical Holdings' (HKG:9997) Statutory Earnings Might Be Conservative3 months ago | Simply Wall St
Does Kangji Medical Holdings Limited (HKG:9997) Create Value For Shareholders?Valuation
Is Kangji Medical Holdings undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 9997 (HK$10.54) is trading below our estimate of fair value (HK$35.26)
Significantly Below Fair Value: 9997 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 9997 is poor value based on its PE Ratio (33.7x) compared to the HK Medical Equipment industry average (29.9x).
PE vs Market: 9997 is poor value based on its PE Ratio (33.7x) compared to the Hong Kong market (11.8x).
Price to Earnings Growth Ratio
PEG Ratio: 9997 is good value based on its PEG Ratio (0.8x)
Price to Book Ratio
PB vs Industry: 9997 is overvalued based on its PB Ratio (3.8x) compared to the HK Medical Equipment industry average (3x).
Future Growth
How is Kangji Medical Holdings forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
42.4%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 9997's forecast earnings growth (42.4% per year) is above the savings rate (1.5%).
Earnings vs Market: 9997's earnings (42.4% per year) are forecast to grow faster than the Hong Kong market (18.3% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 9997's revenue (37.2% per year) is forecast to grow faster than the Hong Kong market (13.3% per year).
High Growth Revenue: 9997's revenue (37.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 9997's Return on Equity is forecast to be high in 3 years time (23.1%)
Past Performance
How has Kangji Medical Holdings performed over the past 5 years?
21.3%
Last years earnings growth
Earnings and Revenue History
Quality Earnings: 9997 has high quality earnings.
Growing Profit Margin: 9997's current net profit margins (48.9%) are higher than last year (41%).
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if 9997's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare 9997's past year earnings growth to its 5-year average.
Earnings vs Industry: 9997 earnings growth over the past year (21.3%) exceeded the Medical Equipment industry 19.7%.
Return on Equity
High ROE: 9997's Return on Equity (8.8%) is considered low.
Financial Health
How is Kangji Medical Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: 9997's short term assets (CN¥2.9B) exceed its short term liabilities (CN¥75.4M).
Long Term Liabilities: 9997's short term assets (CN¥2.9B) exceed its long term liabilities (CN¥8.2M).
Debt to Equity History and Analysis
Debt Level: 9997 is debt free.
Reducing Debt: 9997 has not had any debt for past 5 years.
Debt Coverage: 9997 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 9997 has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Dividend
What is Kangji Medical Holdings's current dividend yield, its reliability and sustainability?
0.42%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 9997's dividend (0.42%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (1.95%).
High Dividend: 9997's dividend (0.42%) is low compared to the top 25% of dividend payers in the Hong Kong market (5.98%).
Stability and Growth of Payments
Stable Dividend: 9997 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are stable.
Growing Dividend: 9997 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: 9997 is not paying a notable dividend for the Hong Kong market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 9997's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
CEO
Ming Zhong
no data
Tenure
Mr. Ming Zhong serve a Chairman & Chief Executive Officer of kangji Medical Holdings Limited.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: 9997 only recently listed within the past 12 months.
Top Shareholders
Company Information
Kangji Medical Holdings Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Kangji Medical Holdings Limited
- Ticker: 9997
- Exchange: SEHK
- Founded: 2004
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: HK$12.259b
- Shares outstanding: 1.25b
- Website: https://www.kangjimedical.com
Number of Employees
Location
- Kangji Medical Holdings Limited
- Tonglu Economic Development Zone
- No. 1668 Chunjiang East Road
- Hangzhou
- Zhejiang Province
- China
Listings
Biography
Kangji Medical Holdings Limited, through its subsidiaries, engages in the research, development, manufacture, and sale of minimally invasive surgical instruments and accessories in China. It offers disposa...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/04/19 10:26 |
| End of Day Share Price | 2021/04/19 00:00 |
| Earnings | 2020/12/31 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.